Open AccessBlocking leukotrienes optimize asthma control: The BLOC survey
Author(s) -
Majdy Idrees,
Mohamed S Al Moamary
Publication year - 2007
Publication title -
annals of thoracic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.639
H-Index - 33
eISSN - 1817-1737
pISSN - 1998-3557
DOI - 10.4103/1817-1737.33696
Subject(s) - montelukast , medicine , asthma , bronchodilator , corticosteroid , leukotriene , pediatrics , population , anesthesia , leukotriene receptor , environmental health
The aim of this study was to evaluate asthma control after the introduction of a leukotriene modifier (Montelukast), in addition to the current controller asthma therapies, in patients with inadequately controlled mild-to-moderate persistent asthma. Asthma control and patient perception were assessed prior to, and 4 weeks after, the introduction of Montelukast, and the pre-introduction and post-introduction results were compared.